USP Monographs Should Be Developed By Public/Private Partnership, Congress Says
This article was originally published in The Pink Sheet Daily
Executive Summary
FDA is urged to seek adequate funding in the FY 2006 budget request to support the effort to increase the number of formal monographs for drug compounding, the report for the FY 2005 spending bill states. The bill provides FDA with $1.79 bil.
You may also be interested in...
USP Will Consider Setting Pharmacy Compounding Standards
The U.S. Pharmacopeia will consider a resolution on setting pharmacy compounding standards at its upcoming 2005 convention
USP Will Consider Setting Pharmacy Compounding Standards
The U.S. Pharmacopeia will consider a resolution on setting pharmacy compounding standards at its upcoming 2005 convention
FDA Drug Compounding Enforcement Continues With Teregen Labs Citation
The Gentere subsidiary distributes compounded drug products for those commercially available and without valid prescriptions, an FDA warning letter states. The agency also cites the firm for cGMP violations.